.svg)
Genetic Testing
Making precision testing the standard of care
Arboretum's genetic testing helps doctors diagnose and understand risk for common diseases, helping providers identify the most effective treatments—at no cost to qualified patients.
Scaling Genetic Testing
Operationally Simple, Scientifically Rigorous, Financially Viable
Clinical Guidelines Are Rapidly Expanding Coverage for Genetic Testing
Clinical guidelines for hereditary risk testing in common diseases are evolving faster than ever. What began with limited indications for breast cancer and Lynch syndrome has expanded to encompass multi-gene cancer panels, cardiovascular conditions, and metabolic diseases.
As these guidelines expand, payer coverage follows—making genetic testing increasingly accessible for the conditions affecting the most people. This shift represents a fundamental change: precision medicine, once reserved for rare diseases and cancer, is becoming the standard of care for heart disease, diabetes, and other common conditions.
Arboretum Enables Healthcare Systems to Deliver Precision Care
Our approach is designed around real-world healthcare system constraints. We provide world-renowned genomics expertise and proprietary comprehensive genetic risk assessment methods without requiring systems to build these capabilities in-house. Digital workflows with automated eligibility checks and patient-friendly cost estimations streamline the testing process.
On-demand genetic counseling and specialist referral support ensure patients receive expert guidance when they need it. These programs are financially sustainable because they're built on reimbursable testing for conditions where genetic information directly impacts clinical management and treatment decisions. As clinical guidelines expand, Arboretum is your partner for seamless implementation into the point of care.
Our Tests
Arboretum offers comprehensive genetic testing for hereditary risks across cardiovascular disease and cancer, with additional offerings coming soon. Our tests combine monogenic variant detection with polygenic risk scores, providing a complete picture of disease risk. All tests are designed for payer reimbursement with clear clinical guidelines, making precision medicine accessible for common diseases at scale
Hereditary Cancer Tests
Hereditary Cardiovascular Tests
These findings lead to immediate personalized care (increased screenings, advanced imaging, therapy changes, lifestyle mods and we are building the pipeline of more personalized therapies for the future)
Our offerings
A Fully Integrated Approach to Precision Medicine
Solutions that Advance Precision Medicine at the Point of Care
- Supports earlier identification of patients at risk for common and complex diseases across diverse patient populations
- Integrates into existing clinical workflows without requiring healthcare systems to build or operate diagnostic infrastructure
- Provides comprehensive testing programs with clear clinical guidelines, scalable software for eligibility screening and ordering, remote and in person sample collection options, and on-demand genetic counseling
- Adapts to meet clinician needs and emerging evidence with an agile test development life cycle
Longitudinal Patient Registry that accelerates Translational Research
- Operates in partnership with healthcare systems to provide tested patients with free additional clinical test results, access to clinical trials, and the opportunity to contribute to medical advancement
- Organizes clinical and genomic research data and provides a secure, compliant research platform for data storage and researcher analysis, with minimal IT burden
Clinical Trial Pipelines that build centers of excellence
- Sources relevant clinical trial opportunities using biomarker-based trial matching across tested populations
- Powers healthcare systems’ competitive advantages in trial recruitment, strengthens research portfolios, and provides patients with access to cutting-edge therapies
- Positions healthcare systems as leaders in translational research and precision medicine implementation
Understanding Genetic Testing and Precision Medicine
Precision medicine tailors treatment to individual biology rather than using the same approach for everyone. Genetic testing is the foundation of this approach, revealing health information that routine tests can't detect and enabling doctors to make more informed decisions about prevention, diagnosis, and treatment.
What is Precision Medicine?
For most of medical history, treatments have been designed for the "average" patient. Your genes, lifestyle, and environment all influence your risk of developing certain conditions and how well specific treatments will work for you. For decades, precision medicine has transformed care for cancer and rare diseases—patients with specific genetic profiles receive targeted therapies that work better and have fewer side effects than one-size-fits-all approaches. Now, the same scientific advances are making it possible to personalize care for common conditions like heart disease and diabetes that affect millions of people.
How Genetic Testing Enables Precision Care
Genetic testing reveals information about your health that routine medical tests can't detect. By analyzing DNA, doctors can diagnose common diseases and identify inherited risks for heart disease, certain cancers, and other serious conditions—often years or decades before symptoms appear. Comprehensive genetic tests examine both rare variants that significantly increase disease risk and common genetic variations that, combined, influence likelihood of developing certain conditions. This clearer picture of health risks enables early intervention, personalized treatment plans, and access to cutting-edge clinical trials.